Scan copy application and routine permits allowed by The Central Board of Narcotics

▴ Scan copy application and routine permits allowed by The Central Board of Narcotics
Once the lockdown is lifted by the Union the exporter/importer of Narcotics Drugs/ Psychotropic Substances and Controlled Substances need to submit the hard copies of the original import certificate within the period of 15 days of uplifting the lockdown.

The Central Board of allowed(CBN) allowed scanned copy of the application, along with the self-authenticated copies of all the documents and routine permits with 48 hours prior permission for export/import of Narcotic Drugs/Psychotropic Substances and Controlled Substances amid the nationwide lockdown.
The Indian Drug Manufacturers’ Association made a representation to the CBN, on March 27, 2020, that due to the lockdown in the country pharma companies are facing non-functioning of courier companies or speed post or delay in deliveries. The exporters/importers of Narcotic Drugs/Psychotropic Substances/Controlled Substances are hence facing difficulties.
Keeping in view the market situation due to COVID-19, the CBN issued a notification allowing the exporters/importers of Narcotic Drugs/ Psychotropic Substances/Controlled Substances to submit the scanned copy of the application, along with self-authenticated copies of all the documents on the email id [email protected]/supdt [email protected]/[email protected] for Narcotic Drugs/Psychotropic Substances/ Controlled Substances.
This, however is a temporary move and once the lockdown is lifted by the Union Government, the exporters/importers needs to submit the hard copies of the original import certificate within a period of 15 days of uplifting of the lockdown.
Devesh Malladi, Chairman, NDPS Committee, IDMA, said, “We see the government is working round-the-clock for making things easier for the pharma industry. They have taken into consideration our raised issues and in a difficult time due to COVID-19, and nationwide lockdown they reverted positively. We had requested the CBN, and accepted the industry’s plea and with this, we will submit the scanned copy of application which CBN can upload on the customs portal ICEGATE Indian Customs EDI Gateway), which will ease out the process of application of the exporter/ importer of Narcotic Drugs/Psychotropic Substances/Controlled Substances.”
Malladi emphasised, “It is a very robust portal, much better than our SUGAM portal. It has started functioning immediately for us.”
He explained, “We will be further requesting to the concerned authority to consider extending it from 15 days to minimum 30 days because our country might lift the lockdown, but the situation might not be the same in the importing country. And knowing the fact that most of the international borders are closed and very limited flights/ freighters/special cargo are functioning. In that case, getting a hardcopy from the importing countries will be a challenging affair. Hence, we will be making another representation to the respective authority.”
Commenting on the routine permits, with 48 hours’ prior permission, he said, ” We sought that too, because most of the international borders are closed and the government has banned incoming and outgoing flights to prevent the spread of community transmission of coronavirus in the country. And in such a pandemic situation, maintaining an original routine, which was mentioned in the original permit, is not possible and the revised routine will take three weeks, which is a long period.”

Tags : #Narcotics #CBN #export #import #lockdown

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in IndiaMay 13, 2024
Setback for Organ Transplantion: First Human to Receive Pig Kidney DiesMay 13, 2024
Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024
Achieving Healthier Lifestyles: Understanding India's New Dietary GuidelinesMay 11, 2024
The Link Between Childhood Sleep and Adult Psychosis: A Critical AnalysisMay 11, 2024
Uncovering Immunization Gaps: Insights into Measles Vaccination Challenges in IndiaMay 11, 2024
Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024